Catheter Precision, Inc. (VTAK) Form 424B3 — Jul 10, 2026
Catheter Precision has filed a prospectus supplement to register 68,067,042 shares of common stock for resale by selling stockholders, a move that could dilute existing shareholders by approximately 25 times the current float. The registered shares include those issuable upon conversion of Series C, D, and J preferred stock and exercise of Series M warrants, all issued previously in connection with private placements and the acquisition of Fly Flyte, Inc. The company states that existing stockholder interest could be reduced to roughly 3.8% if the maximum number of shares is issued.
Key figures
- Cash Position
- 441000
- Deal Value Usd
- 11554827
- Shares Offered
- 68067042
- Dilution multiple
- approximately 25.3 times
- Working capital deficit
- 18500000
- Acquisition note payable
- 5000000
- Shares outstanding prior
- 3609471
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.